Loading
Insider Decl.
20
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€329,846
10 ops. · all time
Who traded when
BuySaleDaniel Pretorius1 sale
Dean Lindecke1 sale
Henriette Hooijer1 sale
Henry Gouws1 sale
Jacobus Schoeman1 sale
Kevin Kruger1 sale
+4 other insiders
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 15 of 26,290 companies
95.8
score / 100
Value100
Quality92
FCF yld92%
Earn yld·
EV/EBITDA0.4x
ROE39%
Gross mgn53%
Net mgn38%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended June 2026 · cache
US$2.68
Analyst consensus
Income statement
RevenueUS$11.2B
Gross profitUS$6B53% margin
EBITDAUS$6.5B58% margin
Net incomeUS$4.3B38.1% margin
Valuation
PER (trailing)9.2x
P/Book3.0x
Beta0.48
Balance sheet & cash
Market capUS$2.3B
Total debtUS$11.4M
Free Cash FlowUS$2.1B
Debt / Equity0%
Profitability & ownership
ROE39.3%
ROA24.0%
% insiders50.0%
% institutions18.3%
Last declaration on 3 September 2026
Declarations20 total
12,198 shares0Ordinary SharesSEC:0002119291-26-000006:0
5,490 shares@ US$2.75450.0006% mcap100.0% of flowOrdinary SharesSEC:0002119291-26-000006:1
18,472 shares0Ordinary SharesSEC:0002114034-26-000006:0
16,801 shares0Ordinary SharesSEC:0002114046-26-000006:0
35,537 shares0Ordinary SharesSEC:0002114067-26-000006:0
11,721 shares0Ordinary SharesSEC:0002114274-26-000006:0
11,586 shares0Ordinary SharesSEC:0002119220-26-000006:0
20,060 shares0Ordinary SharesSEC:0002119238-26-000008:0
9,029 shares0Ordinary SharesSEC:0002119288-26-000008:0
16,826 shares0Ordinary SharesSEC:0002114019-26-000006:0
19,403 shares0Ordinary SharesSEC:0002114041-26-000006:0
16,826 shares@ US$2.75450.0020% mcap100.0% of flowOrdinary SharesSEC:0002114019-26-000006:1
8,313 shares@ US$2.75450.0010% mcap100.0% of flowOrdinary SharesSEC:0002114034-26-000006:1
19,403 shares@ US$2.75450.0023% mcap100.0% of flowOrdinary SharesSEC:0002114041-26-000006:1
7,561 shares@ US$2.75450.0009% mcap100.0% of flowOrdinary SharesSEC:0002114046-26-000006:1
35,537 shares@ US$2.75450.0041% mcap100.0% of flowOrdinary SharesSEC:0002114067-26-000006:1
5,275 shares@ US$2.75450.0006% mcap100.0% of flowOrdinary SharesSEC:0002114274-26-000006:1
11,586 shares@ US$2.75450.0013% mcap100.0% of flowOrdinary SharesSEC:0002119220-26-000006:1
20,060 shares@ US$2.75450.0023% mcap100.0% of flowOrdinary SharesSEC:0002119238-26-000008:1
9,029 shares@ US$2.75450.0010% mcap100.0% of flowOrdinary SharesSEC:0002119288-26-000008:1
20 of 20 declarations
About Drdgold Ltd
All 20 Drdgold Ltd filings come from the same publication, on September 3, 2026, and cover trades from August 13 to September 1, 2026. They consist of 10 sales, 8 option exercises and 2 grants, with no purchase. Sales total EUR 329,846, with a median of EUR 24,446.
The three largest were made on September 1, 2026: EUR 84,280 for Daniel Pretorius (Chief Executive Officer), EUR 47,575 for Dean Lindecke (General Manager Ergo Ops.) and EUR 46,017 for Jacobus Schoeman (Chief Operating Officer). Five filers have 2 filings each, one of them a sale: Ryno Bornman (Financial Manager Ergo Ops.), Henriette Hooijer (Chief Financial Officer), Kevin Kruger (Head of Technical Services), Daniel Pretorius and Mpho Mashatola (Group Fin. & Business Dev. Mgr).
Read moreShow less
The median publication delay is 12 days. The company is worth USD 2.3 billion and half of its capital, 50%, is held by insiders. The 20 filings make up the whole of the last twelve months, of which 10 sales.
